End
1 :

Hint : 🦶 Urate goal <6.

Correct Answers:

  • Serum uric acid level of 5.8 mg/dL


Rationale :

🟦 Allopurinol lowers serum uric acid by inhibiting xanthine oxidase, which decreases uric acid production.

🟦 A serum uric acid of 5.8 mg/dL reflects movement toward the therapeutic target (often < 6 mg/dL for gout control).

🟦 When uric acid is controlled, urate crystal formation decreases, reducing gout flares and long-term joint damage.

🟦 This lab value shows the medication is achieving the desired effect of reducing hyperuricemia, the root cause of gout.

🟦 Monitoring uric acid is a direct way to evaluate therapy because it measures the primary treatment goal of allopurinol.

Creatinine 1.4 mg/dL:

🟦This reflects kidney function, not allopurinol’s primary therapeutic endpoint.

🟦 It may affect dosing, but it does not confirm uric acid control.

Glucose 130 mg/dL:

🟦This is related to glycemic status, not gout urate-lowering effect.

🟦It does not measure allopurinol response.

WBC 11,000/mm³:

🟦This can indicate infection/inflammation, but it is not a marker of uric acid reduction.

🟦WBC does not evaluate allopurinol’s mechanism.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

QLexNursing Calculator Click & Drag ×
AC
(
)
CE
π
e
φ
τ
Inv
sin-1
cos-1
tan-1
log
ln
!
deg
√
x²
x³
^
7
8
9
÷
4
5
6
×
1
2
3
-
0
.
exp
+
Rnd
Ans
=